Mutant plasmid as well as preparation method and application thereof

By constructing the mutant plasmid pCBFR2-2bPT-PSTVd1-200, combined with the conserved sequence of cucumber mosaic virus RNA2 and potato spindle tuber virus, the prevention and aphid transmission problems of potato spindle tuber virus were solved, and effective protection of potatoes was achieved and the reduction of virus replication.

CN118995804AActive Publication Date: 2024-11-22QINGDAO AGRI UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411479723.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-23
Publication Date
2024-11-22
Estimated Expiration
2044-10-23

AI Technical Summary

Technical Problem

Potato spindle tuber viruses cause serious damage to potato yield and quality, and the existing technology is difficult to effectively prevent and control, and there are biosafety risks for aphids to spread viruses.

Method used

A mutant plasmid pCBFR2-2bPT-PSTVd1-200 is constructed, containing the mutant sequence of cucumber mosaic virus RNA2 and the conserved sequence of potato spindle tuber virus, and mixed with RNA1 and modified RNA3 plasmid of CMVFny isolate, using To prevent potato spindle tuber viruses, reduce the risk of aphid transmission.

Benefits of technology

As an attenuated vaccine, this plasmid can effectively prevent the invasion of potato spindle tuber viruses, exist stably in the plant, reduce the efficiency of aphids spreading virus, provide the prevention and treatment potential of a variety of PSTVd ​​isolates, and significantly reduce the amount of virus replication .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995804A_ABST
    Figure CN118995804A_ABST
Patent Text Reader

Abstract

The invention relates to a mutant plasmid as well as a preparation method and application thereof, and belongs to the field of plant virology and molecular biology. The mutant plasmid pCBFR2-2bPT-PSTVd1-200 contains an RNA2 full-length sequence of a CMVFny isolate, and TAATAG and a PSTVd fragment are inserted between the 2682 site and the 2683 site of the mutant plasmid pCBFR2-2bPT-PSTVd1-200; the nucleotide sequence of the PSTVd fragment is as shown in SEQ ID NO. 1. A CMVFny isolate RNA1 and a modified PCB301-RNA3-apno plasmid are pre-mixed and inoculated with the mutant plasmid disclosed by the invention, the attenuated vaccine can prevent harm caused by potato spindle tuber viroid, meanwhile, aphids are prevented from spreading viruses in the field, the effect is good, and a vaccine material and an effective measure are provided for preventing and treating PSTVd in the field.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the fields of plant virology and molecular biology, and relates to a mutant plasmid and a preparation method and application thereof, and in particular to a mutant plasmid for preventing potato spindle tuber viroids. Background Art

[0002] Plant virus disease is the second largest plant disease in agricultural production after fungal diseases. It causes varying degrees of damage to a variety of crops. After infecting crops, it can significantly inhibit crop growth and reduce their quality and yield. Solanum tuberosum .) Potato has become the world's fourth largest food crop due to its excellent planting adaptability and rich nutritional value. Potato virus disease has become an important limiting factor in the development of potato production and the increase of potato yield. Virus infection alone can lead to up to 75% yield loss.

[0003] Cucumber mosaic virus has the characteristics of a wide host and can infect more than 1,200 species of plants from more than 100 families. It can cause symptoms including mottling, slow growth, yellowing, dwarfing, leaf deformity and whole plant necrosis. It is one of the most serious diseases in my country. Therefore, this patent selects cucumber mosaic virus as the vaccine skeleton, which can be used for the development of vaccines for various crop viral diseases.

[0004] Potato spindle tuber disease is caused by viroids. Only two types of viroids can infect potatoes. Among them, potato spindle tuber viroids have a serious and significant impact on the quality and yield of potatoes and are one of the quarantine diseases. Infected plants often show reduced branches, smaller leaves, sharp petioles, and sometimes dark red and wrinkled top leaves. Sometimes the stems are hardened. The symptoms are most obvious in potato tubers. Most tubers are spindle-shaped or long, and some varieties have cracks on the surface. It has a very serious impact on the yield and quality of potatoes, causing potatoes to lose their economic value.

[0005] The main vector of cucumber mosaic virus in the field is aphids. Its insect transmission factor is mainly determined by the CP protein of CMV, and CP protein is the only virus product required for the virus aphid transmission process. A change in an amino acid will affect the characteristics of the plant. The CP gene of the natural mutant strain of cucumber mosaic virus CMV-M was sequenced and a large number of studies were conducted. It was found that a single amino acid change in the CP gene may affect the transmission of aphids. The CMV-M strain does not have the ability to be transmitted by insects in peach aphids, and the transmission efficiency in cotton aphids is extremely low, but the Fny strain can be well transmitted by aphids. Through the comparative study of the CP proteins of the two strains, it was concluded that the changes in amino acids at positions 129 and 162 play a decisive role in the transmission of cotton aphids in cucumber mosaic virus.

[0006] With the development of genetic engineering and biotechnology, especially in the field of genetic engineering cross protection, new methods for preventing and treating potato virus diseases have emerged. The attenuated vaccine is inoculated into plants that are prone to or infected with certain viruses. When the vaccinated plants are infected with the virus again, the plants will be immune and the attenuated vaccine will not harm the host. The attenuated vaccine has the advantages of stability, wide range of resistance, no environmental pollution, and harmlessness to non-target organisms. In order to use a single dose of attenuated vaccine to prevent and treat multiple viruses at the same time, different foreign virus fragments can be inserted into the backbone virus to achieve the purpose of preventing and treating the backbone virus and the target virus corresponding to the inserted fragment. This patent uses cucumber mosaic virus as the basic virus vector, and can be a bivalent attenuated vaccine that can resist cucumber mosaic virus and potato spindle tuber viroids, and at the same time prevent aphids from transmitting the virus in the field. There is no report yet. Summary of the invention

[0007] In view of the above problems, the present invention provides a mutant plasmid for preventing potato spindle tuber viroids, a preparation method and an application thereof, and specifically relates to a mutant plasmid containing cucumber mosaic virus (CMV) RNA2, which is combined with a CMV-containing mutant plasmid to form a mutant plasmid. Fny The RNA1 of the isolate and the modified RNA3 plasmid are mixed and inoculated to prevent the mutant plasmid and its application from aphids from spreading the virus while preventing potato spindle tuber viroid (PSTVd). The present invention provides vaccine materials and effective prevention and control measures for field prevention and control of plant virus diseases caused by PSTVd. The technical scheme of the present invention is as follows: In the first aspect of the present invention, a mutant plasmid for preventing potato spindle tuber viroid is constructed, named pCB F R2-2bPT-PSTVd 1-200 The plasmid is a mutant plasmid of cucumber mosaic virus (CMV) RNA2, which contains CMV Fny The full-length sequence of RNA2 of the isolate has TAATAG and a conservative sequence of potato spindle tuber viroid (PSTVd) inserted between positions 2682 and 2683; the nucleotide sequence of the PSTVd ​​fragment is shown in SEQ ID NO.1, and the nucleotide sequence of the mutant RNA2 in the plasmid is shown in SEQ ID NO.2.

[0008] The second aspect of the present invention provides a method for preparing the mutant plasmid, comprising the following steps: The PSTVd ​​gene fragment shown in SEQ ID NO.1 was inserted into the intermediate vector pCB using enzyme digestion and ligation methods. F R2-2bPT (This plasmid contains CMV FnyThe full-length sequence of RNA 2 of the isolate was obtained, and TAATAG and Sma I restriction site were inserted at positions 2682 and 2683 to construct a mutant plasmid of cucumber mosaic virus (CMV) RNA2.

[0009] In the third aspect of the present invention, the mutant plasmid pCB F R2-2bPT-PSTVd 1-200 Application in preventing potato spindle tuber viroid; the application steps are as follows: pCB F R2-2bPT-PSTVd 1-200 Transform Agrobacterium with CMV Fny Isolate RNA1 and mutant plasmid PCB301-RNA3- △ The plasmid Agrobacterium of apno is mixed and pre-inoculated on potatoes to achieve the application effect of preventing and controlling potato spindle tuber viroids.

[0010] The mutant plasmid PCB301-RNA3- △ The nucleotide sequence of apno is shown in SEQ ID NO.3; This plasmid contains CMV Fny The full-length sequence of RNA3 of the isolate was obtained, and point mutations were performed on the 129th and 162nd amino acids, such that the proline at position 129 was mutated to alanine, and the leucine at position 162 was mutated to threonine.

[0011] Beneficial effects of the present invention: (1) For the obtained cucumber mosaic virus RNA2 2b protein premature termination mutant pCB F R2-2bPT, the present invention further inserts the PSTVd ​​conservative fragment after the new termination codon to obtain the 2b protein premature termination mutant of cucumber mosaic virus RNA2 containing the PSTVd ​​fragment. Fny Mixed inoculation of the isolate RNA1 and the modified RNA3 plasmid can prevent infection by the highly virulent strain of PSTVd ​​and can be used as a attenuated vaccine against potato spindle tuber viroids.

[0012] (2) The mutant plasmid PCB301-RNA3- △ apno makes point mutations at the 129th and 162nd amino acids. The mutated vaccine can stably exist in the plant without affecting other functions, thus avoiding the biosafety risks caused by the spread of aphids during vaccination.

[0013] (3) After the plasmid is transformed into Agrobacterium, the mutant plasmid pCB F R2-2bPT-PSTVd1-200 With CMV Fny Wild-type RNA1 and plasmid PCB301-RNA3- △ The plants pre-inoculated with Agrobacterium mixed with apno and the plants pre-inoculated with the mutant had a certain preventive effect against PSTVd.

[0014] (4) The PSTVd ​​gene fragment inserted into the mutant plasmid provided by the present invention is a 200 bp long PSTVd ​​genome conservative sequence, which has the potential to prevent and treat a variety of PSTVd ​​isolates. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 Schematic diagram of the vector; (a) is the basic vector pCB301-CMV Fny -R2 schematic diagram, (b) is the intermediate vector pCB F Schematic diagram of R2-2bPT, (c) is the attenuated mutant pCB containing PSTVd F R2-2bPT-PSTVd 1-200 Schematic diagram; LB is the left border of the T-DNA region; RB is the right border of the T-DNA region; 35S is the promoter (2x35S); RZ is the ribozyme (HDV ribozyme); NOS is the terminator (NOS terminator).

[0016] Figure 2 Symptoms of potatoes vaccinated with attenuated vaccines against aphid-transmitted key site mutants; blank is the potato control without any treatment; R1 is CMV Fny RNA1; R2 is CMV Fny RNA2; R3 is CMV Fny RNA3; R3- △ apno is a key site mutant of aphid transmission, PCB301-RNA3- △ apno;R2-PSTVd 1-200 Attenuated vaccine pCBFR2-2bPT-PSTVd 1-200 ; R1 / R2 / R3 were inoculated with wild-type CMV Fny Treatment of Nicotiana benthamiana plants; R1 / R2-PSTVd 1-200 / R3- △ apno is a treatment for potato plants inoculated with a attenuated vaccine of aphid-transmitted key site mutants.

[0017] Figure 3 pCBFR2-2bPT-PSTVd 1-200 Weak disease symptoms on potato variety Chapoti; Blank is the control of potato plants without any treatment; R1 is CMV FnyRNA1; R2 is CMV Fny RNA2; R3 is CMV Fny RNA3; pCBFR2-2bPT-PSTVd 1-200 Contains CMV Fny The entire RNA2 sequence is inserted into the 1-200 bp conservative sequence of PSTVd ​​after the premature termination codon of the 2b protein; R3- △ apno is a key site mutant of aphid transmission, PCB301-RNA3- △ apno; R1 / R2-PSTVd 1-200 / R3- △ apno is inoculated with R1+PCB301-RNA3- △ apno+pCBFR2-2bPT-PSTVd 1-200 PSTVd ​​refers to potato treatments inoculated with PSTVd ​​after inoculation; PSTVd ​​refers to potato treatments inoculated with PSTVd ​​by friction; dpi refers to days after inoculation.

[0018] Figure 4 R1+pCB301-RNA3- △ apno+pCBFR2-2bPT-PSTVd 1-200 3d RT-PCR test after inoculation on potato variety Chapotri; M is D2000 molecular weight standard of Tiangen Company; Blank is potato plant control without any treatment; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCBFR2-2bPT-PSTVd 1-200 Contains CMV Fny The entire RNA2 sequence is inserted into the 1-200 bp conserved sequence of PSTVd ​​after the premature termination codon of the 2b protein; R3- △ apno, aphid transmission key site mutant PCB301-RNA3- △ apno; R1 / R2-PSTVd 1-200 / R3- △ apno is inoculated with R1+pCB301-RNA3- △ apno+pCBFR2-2bPT-PSTVd 1-200 The potato variety Shapoti was treated with CK as the negative control.

[0019] Figure 5 This is the RT-PCR detection diagram of potato variety Chapoti after friction inoculation of PSTV for 3 days; M is the D2000 molecular weight standard of Tiangen Company; Blank is the potato control without any treatment; R1 is CMV FnyRNA1; R3 is CMV Fny RNA3; pCBFR2-2bPT-PSTVd 1-200 Contains CMV Fny The entire RNA2 sequence was inserted into the 2b protein after the premature termination codon of the PSTVd ​​200 bp conservative sequence; R3- △ apno is a key site mutant of aphid transmission pCB301-RNA3- △ apno; R1 / R2-PSTVd 1-200 / R3- △ apno is inoculated with R1+pCB301-RNA3- △ apno+pCBFR2-2bPT-PSTVd 1-200 The treatment of potato variety Shapoti inoculated with PSTVd ​​was post-inoculated; PSTVd ​​was the treatment of potato variety Shapoti inoculated with PSTVd ​​by friction; CK was the negative control.

[0020] Figure 6 Figure 3 shows the viral replication in potato variety Chapoti after friction inoculation with PSTV for 3, 6, 9, and 12 days; vaccine treatment group, inoculated with R1+pCB301-RNA3- △ Potatoes inoculated with PSTVd ​​after apno+pCBFR2-2bPT-PSTVd1-200; strong toxin treatment group, repeated three times. Figure 7 The fluorescence quantitative curves on potato Schefflera after friction inoculation with PSTVd; among them, (a) is the fluorescence quantitative curve three days after the strong attack of PSTVd, (b) is the fluorescence quantitative curve six days after the strong attack of PSTVd, (c) is the fluorescence quantitative curve nine days after the strong attack of PSTVd, and (d) is the fluorescence quantitative curve twelve days after the strong attack of PSTVd.

[0021] Figure 8 pCBFR2-2bPT-PSTVd 1-200 Weak disease symptoms on potato variety Kexing No. 1; Blank is a control of potato plants without any treatment; R1 is CMV Fny RNA1; R2 is CMV Fny RNA2; R3 is CMV Fny RNA3; pCBFR2-2bPT-PSTVd 1-200 Contains CMV Fny The entire RNA2 sequence is inserted into the 1-200 bp conserved sequence of PSTVd ​​after the premature termination codon of the 2b protein; R3- △ apno is a key site mutant of aphid transmission pCB301-RNA3- △apno; R1 / R2-PSTVd 1-200 / R3- △ apno is inoculated with R1+pCB301-RNA3- △ apno+pCBFR2-2bPT-PSTVd 1-200 PSTVd ​​refers to potato treatments inoculated with PSTVd ​​after inoculation; PSTVd ​​refers to potato treatments inoculated with PSTVd ​​by friction; dpi refers to days after inoculation.

[0022] Fig. 9 R1+pCB301-RNA3- △ apno+pCBFR2-2bPT-PSTVd 1-200 3d RT-PCR test diagram of inoculation on potato variety Kexing No. 1; M is the D2000 molecular weight standard of Tiangen Company; Blank is the potato plant control without any treatment; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCBFR2-2bPT-PSTVd 1-200 Contains CMV Fny The entire RNA2 sequence is inserted into the 1-200 bp conserved sequence of PSTVd ​​after the premature termination codon of the 2b protein; R3- △ apno is a key site mutant of aphid transmission pCB301-RNA3- △ apno; R1 / R2-PSTVd 1-200 / R3- △ apno is inoculated with R1+PCB301-RNA3- △ apno+pCBFR2-2bPT-PSTVd 1-200 The potato variety Kexing No. 1 was treated with this treatment; CK was the negative control.

[0023] Fig.10 RT-PCR detection on potato variety Kexing No. 1 3 days after friction inoculation with PSTVd; M is the D2000 molecular weight standard of Tiangen Company; Blank is the potato plant without any treatment; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCBFR2-2bPT-PSTVd 1-200 Contains CMV Fny The entire RNA2 sequence and the 200 bp conserved sequence of PSTVd ​​were inserted after the premature stop codon of the 2b protein; R1 / R2-PSTVd 1-200 / R3- △ apno is inoculated with R1+pCB301-RNA3- △apno+pCBFR2-2bPT-PSTVd 1-200 The treatment of potato variety Kexing No. 1 inoculated with PSTVd ​​later; PSTVd ​​is the treatment of potato variety Kexing No. 1 inoculated with PSTVd ​​by friction; CK is the negative control.

[0024] Fig.11 The viral replication in potato variety Kexing No. 1 was shown at 3, 6, 9, and 12 days after friction inoculation with PSTV; the vaccine treatment group was inoculated with R1+pCB301-RNA3- △ Potatoes inoculated with PSTVd ​​after apno+pCBFR2-2bPT-PSTVd1-200; strong toxin treatment group, repeated three times.

[0025] Fig.12 These are the fluorescence quantitative curves of Potato Killer No. 1 after friction inoculation with PSTVd; among them, (a) is the fluorescence quantitative curve three days after the strong attack of PSTVd, (b) is the fluorescence quantitative curve six days after the strong attack of PSTVd, (c) is the fluorescence quantitative curve nine days after the strong attack of PSTVd, and (d) is the fluorescence quantitative curve twelve days after the strong attack of PSTVd. DETAILED DESCRIPTION

[0026] The technical solution of the present invention is described in detail below through specific implementation methods. It should be understood that the following specific implementation methods are only exemplary, and any changes or modifications should be within the scope of protection of the present invention as long as they do not deviate from the technical solution design of the present invention. The present invention is described in detail below in conjunction with examples.

[0027] The experimental materials used in the examples of the present invention that are not specifically described are all conventional experimental materials in the art and can be purchased through commercial channels. If the specific experimental conditions and methods are not specified in the examples of the present invention, conventional conditions are usually followed, such as J. Sambrook et al., ed., Molecular Cloning Experiment Guide (3rd Edition), Science Press, 2002; DL Spector et al., ed., Cell Experiment Guide, Science Press, 2001; or the conditions recommended by the manufacturer.

[0028] Example 1. pCB F R2-2bPT-PSTVd 1-200 Build Cloning of partial fragments of PSTVd: Total RNA from potato plants infected with PSTVd ​​(U23058.1) was extracted using TRlZol (Invitrogen), and reverse transcription was performed under the action of Reverse Transcriptase M-MLV (AG). The reverse primer was PSTVd-200-R, and the reaction conditions were: denaturation at 80°C for 3 min without adding enzymes; after adding reverse transcriptase, reaction was carried out at 42°C for 1.5 h. Then, the cDNA of the reverse transcription product was used as a template, and the PCR reaction was carried out under the action of 2×Taq Master Mix (AG). The primer pair was PSTVd-1-F and PSTVd-200-R; PCR conditions: 95°C pre-denaturation for 3 min; 95°C denaturation for 15 s, 52°C annealing for 15 s, 72°C extension for 12 s, 30 cycles; 72°C extension for 5 min; 4°C storage; the PCR product was a 200 bp conservative sequence fragment in PSTVd, and the nucleotide sequence was shown in SEQ ID NO.1. The PCR product was recovered by a DNA recovery kit and set aside.

[0029] pCB F R2-2bPT Sma I single enzyme digestion, the digestion product was recovered by DNA recovery kit; the intermediate vector pCB F The R2-2bPT and PSTVd ​​fragments were reacted at 50°C for 15 min under the action of homologous recombinase (Tran); the ligation product was transformed into competent cells of Escherichia coli DH5α, coated with LB plates containing 100 μg / mL kanamycin, and the positive clone pCB was obtained by colony PCR screening and DNA sequencing. F R2-2bPT-PSTVd 1-200 The nucleotide sequence is shown in SEQ ID NO.2. The sequence of the primer PSTVd-1-F used in homologous recombination is shown in SEQ ID NO.4, and the sequence of the primer PSTVd-1-R is shown in SEQ ID NO.5; the construction schematic diagram is shown in Figure 1 shown.

[0030] Result analysis: After the ligation product was transformed, the product was screened by colony PCR and DNA sequencing, confirming that the plasmid contained the PSTVd ​​1-200 bp gene sequence.

[0031] Example 2. PCB301-RNA3- △ apno build Cloning of fragments: Based on the mutation site and the CMV sequence published in GenBank FnyPrimers R3-pd-aphid-F and R3-pd-aphid-R were designed based on the sequence of RNA3 (accession number: D10538.1). RNA3 was amplified by primers and PCR reaction was performed under the action of 2×TaqMaster Mix (AG); PCR conditions: 95°C pre-denaturation for 3 min; 95°C denaturation for 15 s, 60°C annealing for 15 s, 72°C extension for 12 s, 30 cycles; 72°C extension for 5 min; 4°C storage; PCR product is RNA3 fragment after point mutation. The PCR product was recovered by a DNA recovery kit and set aside. The sequence of the primer R3-pd-aphid-F is shown in SEQ ID NO.6, and the sequence of the primer R3-pd-aphid-R is shown in SEQ ID NO.7.

[0032] RNA3 was amplified with primers and PCR reaction was carried out under the action of 2×Taq Master Mix (AG). The primer pair was R3-zt-aphid-F and R3-zt-aphid-R. PCR conditions: 95 ℃ pre-denaturation for 3 min; 95 ℃ denaturation for 15 s, 60 ℃ annealing for 15 s, 72 ℃ extension for 12 s, 30 cycles; 72 ℃ extension for 5 min; 4 ℃ storage; primer sequence digestion products were recovered by DNA recovery kit; the vector and fragment parts were reacted at 50 ℃ for 15 min under the action of homologous recombinase (Tran); the ligation product was transformed into competent cells of Escherichia coli DH5α, and LB plates with 100 μg / mL kanamycin were coated. The positive clone PCB301-RNA3- △ apno, the nucleotide sequence is shown in SEQ ID NO. 3. The sequence of primer R3-zt-aphid-F is shown in SEQ ID NO. 8, and the sequence of primer R3-zt-aphid-R is shown in SEQ ID NO. 9.

[0033] Result analysis: After the ligation product was transformed, the product was screened by colony PCR and DNA sequencing, confirming that the mutant plasmid was successfully constructed.

[0034] The successfully constructed mutant plasmid was transformed into Agrobacterium GV3101 competent cells and incubated with CMV Fny RNA1, pCBFR2-2bPT-PSTVd 1-200 The inoculated potatoes were mixed with Agrobacterium in equal proportions. After 16 days, the inoculated plants showed no obvious symptoms, which proved that the virus was attenuated. Fig.10 shown.

[0035] Example 3. Plasmid vector pCB FR2-2bPT-PSTVd 1-200 Biological effects Agrobacterium infiltration and infection of potatoes: First, wild-type CMV Fny RNA1, pCB F R2-2bPT-PSTVd 1-200 、PCB301-RNA3- △ The plasmids of apno were transformed into competent cells of Agrobacterium GV3101, respectively, and coated with LB plates containing 50 µg / ml kanamycin and 100 µg / ml rifampicin. After culturing at 28°C for 48 h, a single plaque was picked for colony PCR verification, and then a single plaque was picked in 2 ml LB culture medium (50 µg / ml kanamycin, 100 µg / ml rifampicin) and cultured at 28°C, 200 rpm for 24 h.

[0036] Induction: Take CMV-containing Fny RNA1, pCB F R2-2bPT-PSTVd 1-200 、PCB301-RNA3- △ apno, 100 µL of bacterial solution was added to 5 ml of LB culture medium (containing 50 µg / ml kanamycin and 100 µg / ml rifampicin), and cultured at 28°C with shaking at 200 rpm until OD 600 It is 0.4-0.5.

[0037] Resuspension: Place the induced bacterial solution in a 10 ml centrifuge tube and centrifuge at 6000 rpm for 10 min at room temperature; collect the bacterial cells and resuspend them in 1 ml Agrobacterium resuspension solution (10 mM MgCl2, 10 mM MES, 0.1 mM AS) by pipetting and mixing, take 50 ul of bacterial solution to 1 ml of resuspension solution, and measure its OD 600 The concentration was adjusted to obtain OD 600 The OD value of the remaining bacterial solution is 1.2, and the OD value of the remaining bacterial solution is adjusted according to the ratio of the bacterial solution and the resuspension solution. 600 The OD of the three bacterial suspensions was 1.2-1.5. 600 Consistent.

[0038] Adjust the three OD 600 The bacterial solution (containing CMVFnyRNA1, pCB F R2-2bPT-PSTVd 1-200 、PCB301-RNA3- △ apno ) in equal proportions and incubate at 28°C for 3 h.

[0039] Inoculation: Take a 1 ml disposable syringe, remove the needle and absorb the Agrobacterium solution. Select potato Charpoti and Nemesis No. 1 cultured from the tissue culture bottle, and use pressure to inject the solution in the syringe between the veins on the back of the leaf. Inject two leaves per plant, and the injection amount on each leaf should cover at least 1 / 3 of the leaf.

[0040] The inoculated plants were cultured at 25°C with alternating 16 h light / 8 h dark periods.

[0041] Result analysis: Figure 2 CMV vaccination as indicated Fny R1+PCB301-RNA3- △ apno+pCB F R2-2bPT-PSTVd 1-200 The results were basically the same as those of healthy controls, with no obvious symptoms of viral disease. 1-200 It is a weak mutant.

[0042] After starvation treatment of cotton aphids for 4 h, they were inoculated into potato plants R1 / R2 / R3 and R1 / R2-PSTVd 1-200 / R3- △ apno, extract RNA from cotton aphids and test the virus transmission efficiency by RT-PCR. Result analysis: as shown in Table 1.

[0043] Table 1 Aphid transmission efficiency test table

[0044] The constructed PCB301-RNA3- △ apno greatly reduces the efficiency of aphid transmission.

[0045] Example 4. Plasmid vector pCBFR2-2bPT-PSTVd 1-200 Cross-protection effect test Using the method in Example 2, CMV was inoculated Fny RNA1 / RNA2-2bPTⅡ-PSTVd 1-200 / PCB301-RNA3- △ Seven days after the inoculation of the attenuated mutant, the target strong PSTVd ​​was used to infect the plants pre-inoculated with the attenuated mutant and the plants not pre-inoculated with the attenuated mutant to test its cross-protection effect.

[0046] Result analysis: Figure 4 and Fig. 9As shown, RT-PCR detected that the attenuated mutant was stably present 3 days after the attenuated mutant was inoculated into two different varieties of potato plants. Primer information is as follows: the sequence of R3-1351-F is shown in SEQ ID NO.10, and the sequence of R3-1941-R is shown in SEQ ID NO.11; the fragment size is 590 bp.

[0047] like Figure 5 and Fig.10 As shown, RT-PCR detected the stable presence of PSTVd ​​in plants pre-inoculated with attenuated mutants and plants not pre-inoculated with attenuated mutants 3 days after friction inoculation with the juice of PSTVd ​​potato diseased plants. Primer information: the sequence of pstvd-1-F-0516 is shown in SEQ ID NO.12, and the sequence of pstvd-358-R-0516 is shown in SEQ ID NO.13; the fragment size is 358 bp.

[0048] like Figure 6 and Fig.11 The PSTVd ​​strong virus was directly inoculated into potato Charpoti and Kexing No. 1, and the stems were stiff and shorter than normal plants, and the growth was weakened; pre-inoculation with CMV Fny RNA1 / RNA2-2bPTⅡ-PSTVd 1-200 / PCB301-RNA3- △ The potato plants of apno were inoculated with PSTVd ​​and the plant height was slightly shorter than that of the healthy control plants, and the growth condition was good, indicating that the pre-inoculation with CMV Fny RNA1 / RNA2-2bPTⅡ-PSTVd 1-200 / PCB301-RNA3- △ The potato Charpoti and Kexing No. 1 of apno have good cross-protection effect against PSTVd. Since the symptoms of PSTVd ​​on potato leaves are not obvious and there is only a difference in plant height, Realtime PCR was used to quantitatively monitor the replication of the virus in potatoes that were vaccinated with PSTVd ​​and inoculated with PSTVd ​​alone. A nucleotide sequence on the polymerase was selected to design Realtime PCR primers. Total RNA from potato leaves was extracted using RNA Easy Fast Plant Tissue Kit (TIANGEN), reverse transcribed into cDNA using HiScript Ⅲ RTSuperMix for QPCR (Vazyme), and Realtime PCR was performed using 2×Realtime PCR Super mix (Polymer) fluorescent dye. The obtained Realtime PCR data were analyzed using the 2 (-ΔΔCt) method, and the plot was drawn using GraphPad Prism 8.0.2.263 software.

[0049] like Figure 7 and Fig.12 As shown, PSTVd ​​was inoculated on potatoes, and the results showed that the virus replication continued to increase with the extension of inoculation time; Fny RNA1 / RNA2-2bPTⅡ-PSTVd 1-200 / PCB301-RNA3- △ The potatoes of apno were inoculated with the target strong virus (PSTVd). The plants grew well. Fluorescence quantitative PCR showed that the virus replication continued to increase with the extension of inoculation time but was relatively low, indicating that the pre-inoculation of CMV Fny RNA1 / RNA2-2bPTⅡ-PSTVd 1-200 / PCB301-RNA3- △ The potatoes of apno have good cross protection effect against PSTVd.

Claims

1. A mutant plasmid pCB for preventing potato spindle tuber viroid F R2-2bPT-PSTVd 1-200 , It is characterized in that The mutant plasmid contains CMV Fny The full-length RNA2 sequence of the isolate has TAATAG and a PSTVd ​​fragment inserted between positions 2682 and 2683; the nucleotide sequence of the PSTVd ​​fragment is shown in SEQ ID NO.

1.

2. The mutant plasmid pCB according to claim 1 F R2-2bPT-PSTVd 1-200 , It is characterized in that The nucleotide sequence of the mutant plasmid is shown in SEQ ID NO.

2.

3. The mutant plasmid pCB according to claim 1 or 2 F R2-2bPT-PSTVd 1-200 The preparation method of It is characterized in that The steps of the preparation method are as follows: Insert the PSTVd ​​gene fragment shown in SEQ ID NO.1 into the intermediate vector pCB F In R2-2bPT, the intermediate vector pCB F R2-2bPT contains CMV Fny The full-length sequence of RNA 2 of the isolate was obtained, and TAATAG and Sma I restriction sites were inserted at positions 2682 and 2683 to obtain the mutant plasmid pCB F R2-2bPT-PSTVd 1-200 .

4. The mutant plasmid pCB according to claim 1 or 2 F R2-2bPT-PSTVd 1-200 Application in constructing attenuated vaccines against potato spindle tuber viroids.

5. The mutant plasmid pCB according to claim 1 or 2 F R2-2bPT-PSTVd 1-200 Used in the prevention of potato spindle tuber viroid.

6. The use according to claim 5, It is characterized in that The application steps are as follows: pCB F R2-2bPT-PSTVd 1-200 Transform Agrobacterium with CMV Fny Isolate RNA1 and mutant plasmid PCB301-RNA3- △ The plasmid Agrobacterium mixture of apno was pre-inoculated on potatoes; The mutant plasmid PCB301-RNA3- △ The nucleotide sequence of apno is shown in SEQ ID NO.3; This plasmid contains CMV Fny The full-length sequence of RNA3 of the isolate was obtained, and point mutations were performed on the 129th and 162nd amino acids, such that the proline at position 129 was mutated to alanine, and the leucine at position 162 was mutated to threonine.

Citation Information

Patent Citations

  • Cucumber mosaic virus RNA2 attenuated mutant plasmid vector containing potato X virus fragment and application of cucumber mosaic virus RNA2 attenuated mutant plasmid vector

    CN112322652A

  • Duplex attenuated vaccine capable of resisting cucumber mosaic virus and potato virus X and application of duplex attenuated vaccine

    CN112410351A

  • Bivalent attenuated vaccine capable of resisting cucumber mosaic virus and potato virus Y

    CN112961839A

  • Mutant plasmid vector containing cucumber mosaic virus Fny isolate RNA2 and application thereof

    CN113388637A

  • Modified gene-silencing RNA and uses thereof

    CN1646687A